Literature DB >> 35705890

Surgical Ablation of Cardiac Tissue with Nanosecond Pulsed Electric Fields in Swine.

Frency Varghese1,2,3, Jonathan M Philpott4,5, Johanna U Neuber1,2, Barbara Hargrave2,6, Christian W Zemlin7,8,9.   

Abstract

BACKGROUND: Myocardial tissue can be ablated by the application nanosecond pulsed fields (nsPEFs). The applied electric fields irreversibly permeabilize cell membranes and thereby kill myocytes while leaving the extracellular matrix intact.
METHODS: In domestic pigs (n = 10), hearts were exposed via sternotomy and either ablated in vivo ([Formula: see text] = 5) or in excised, Langendorff-perfused hearts ([Formula: see text] = 5). The nsPEFs consisted of 6-36 pulses of 300 ns each, delivered at 3-6 Hz; the voltage applied varied from 10 to 12 kV. Atrial lesions were either created after inserting the bottom jaw of the bipolar clamp into the atrium via a purse string incision (2-3 lesions per atrium) or by clamping a double layer of tissue at the appendages (one lesion per atrium). Ventricular lesions were created after an incision at the apex. The transmurality of each lesion was determined at three points along the lesion using a triphenyl tetrazolium chloride (TTC) stain.
RESULTS: All 27 atrial lesions were transmural. This includes 13/13 purse string lesions (39/39 sections, tissue thickness 2.5-4.5 mm) and 14/14 appendage lesions (42/42 sections, tissue thickness 8-12 mm). All 3 right ventricular lesions were transmural (9/9 sections, 18 pulses per lesion). Left ventricular lesions were always transmural for 36 pulses (3/3 lesions, 9/9 sections). All lesions have highly consistent width across the wall. There were no pulse-induced arrhythmias or other complications during the procedure.
CONCLUSIONS: nsPEF ablation reliably created acute lesions in porcine atrial and ventricular myocardium. It has far better penetration and is faster than both radiofrequency ablation and cryoablation and it is free from thermal side effects.
© 2022. The Author(s) under exclusive licence to Biomedical Engineering Society.

Entities:  

Keywords:  Atrial fibrillation; Cox Maze IV; Irreversible electroporation; Nanosecond ablation; Surgical ablation

Year:  2022        PMID: 35705890     DOI: 10.1007/s13239-022-00634-2

Source DB:  PubMed          Journal:  Cardiovasc Eng Technol        ISSN: 1869-408X            Impact factor:   2.495


  29 in total

1.  Effect of epicardial fat on ablation performance: a three-energy source comparison.

Authors:  Kimberly N Hong; Mark J Russo; Elyse A Liberman; Alex Trzebucki; Mehmet C Oz; Michael Argenziano; Mathew R Williams
Journal:  J Card Surg       Date:  2007 Nov-Dec       Impact factor: 1.620

2.  Biatrial lesion sets.

Authors:  Ralph J Damiano; Rochus K Voeller
Journal:  J Interv Card Electrophysiol       Date:  2007-12       Impact factor: 1.900

3.  The first Maze procedure.

Authors:  James L Cox
Journal:  J Thorac Cardiovasc Surg       Date:  2011-05       Impact factor: 5.209

4.  The Cox-Maze IV procedure for lone atrial fibrillation.

Authors:  Ralph J Damiano; Marci Bailey
Journal:  Multimed Man Cardiothorac Surg       Date:  2007-01-01

5.  5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.

Authors:  Michael J Mack; Martin B Leon; Craig R Smith; D Craig Miller; Jeffrey W Moses; E Murat Tuzcu; John G Webb; Pamela S Douglas; William N Anderson; Eugene H Blackstone; Susheel K Kodali; Raj R Makkar; Gregory P Fontana; Samir Kapadia; Joseph Bavaria; Rebecca T Hahn; Vinod H Thourani; Vasilis Babaliaros; Augusto Pichard; Howard C Herrmann; David L Brown; Mathew Williams; Jodi Akin; Michael J Davidson; Lars G Svensson
Journal:  Lancet       Date:  2015-03-15       Impact factor: 79.321

6.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-09-15       Impact factor: 6.343

Review 7.  Experimental cryosurgery investigations in vivo.

Authors:  A A Gage; J M Baust; J G Baust
Journal:  Cryobiology       Date:  2009-10-13       Impact factor: 2.487

8.  Cryosurgical control of cancer: effects of freeze rates, tumor temperatures, and ischemia.

Authors:  H B Neel; L W DeSanto
Journal:  Ann Otol Rhinol Laryngol       Date:  1973 Sep-Oct       Impact factor: 1.547

9.  Surgical ablation of atrial fibrillation trends and outcomes in North America.

Authors:  Niv Ad; Rakesh M Suri; James S Gammie; Shubin Sheng; Sean M O'Brien; Linda Henry
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-21       Impact factor: 5.209

10.  The long-term outcomes and durability of the Cox-Maze IV procedure for atrial fibrillation.

Authors:  Ali J Khiabani; Robert M MacGregor; Nadia H Bakir; Joshua L Manghelli; Laurie A Sinn; Hersh S Maniar; Marc R Moon; Richard B Schuessler; Spencer J Melby; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2020-05-05       Impact factor: 5.209

View more
  1 in total

1.  Electroporation Parameters for Human Cardiomyocyte Ablation In Vitro.

Authors:  Jara M Baena-Montes; Tony O'Halloran; Cormac Clarke; Kevin Donaghey; Eoghan Dunne; Martin O'Halloran; Leo R Quinlan
Journal:  J Cardiovasc Dev Dis       Date:  2022-07-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.